These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1611628)

  • 1. Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.
    O'Keeffe S; Grimes H; Finn J; McMurrough P; Daly K
    Cardiology; 1992; 80(2):100-5. PubMed ID: 1611628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure.
    Schwinger RH; Antoni DH
    Magnes Res; 1992 Mar; 5(1):29-32. PubMed ID: 1591140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmias during concurrent therapy with captopril and frusemide.
    Daniels AR
    N Z Med J; 1987 Nov; 100(835):695. PubMed ID: 3330600
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of chronic diuretic therapy on serum, lymphocyte and erythrocyte potassium, magnesium and calcium concentrations.
    Abraham AS; Meshulam Z; Rosenmann D; Eylath U
    Cardiology; 1988; 75(1):17-23. PubMed ID: 3342421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure.
    Roudebush P; Allen TA; Kuehn NF; Magerkurth JH; Bowers TL
    J Vet Intern Med; 1994; 8(5):337-42. PubMed ID: 7837109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diuretics on lymphocyte magnesium and potassium.
    Ryan MP; Ryan MF; Counihan TB
    Acta Med Scand Suppl; 1981; 647():153-61. PubMed ID: 6942638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride.
    Ng LL; Garrido MC; Davies JE; Brochwicz-Lewinski MJ; Tan LB
    Br J Clin Pharmacol; 1992 Mar; 33(3):329-32. PubMed ID: 1576058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prolonged nifedipine or captopril therapy on lymphocyte magnesium and potassium levels in hypertension.
    Lavin F; O'Keeffe S; Grimes H; Finn J; Mannion A; Daly K
    Cardiology; 1993; 82(6):405-8. PubMed ID: 8402763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnesium and potassium content in patients with heart failure and in healthy persons. Determination in lymphocytes, erythrocytes and plasma].
    Schwinger RH; Antoni DH
    Z Kardiol; 1990 Nov; 79(11):735-41. PubMed ID: 2278165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements.
    Chan TY; Critchley JA
    Drug Saf; 1992; 7(2):159-61. PubMed ID: 1605901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
    Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiarrhythmic effect of the ACE inhibitor captopril in patients with congestive heart failure largely is due to its potassium sparing effects.
    Poquet F; Ferguson J; Rouleau JL
    Can J Cardiol; 1992; 8(6):589-95. PubMed ID: 1504913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.
    Cohen N; Almoznino-Sarafian D; Zaidenstein R; Alon I; Gorelik O; Shteinshnaider M; Chachashvily S; Averbukh Z; Golik A; Chen-Levy Z; Modai D
    Heart; 2003 Apr; 89(4):411-6. PubMed ID: 12639869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.
    Stevenson RN; Keywood C; Amadi AA; Davies JR; Patterson DL
    Br Heart J; 1991 Jul; 66(1):19-21. PubMed ID: 1854570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
    Boccanelli A; Zachara E; Liberatore SM; Carboni GP; Prati PL
    Postgrad Med J; 1986; 62 Suppl 1():184-7. PubMed ID: 3534859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril on lymphocyte sodium, potassium, magnesium and calcium levels in patients with severe congestive heart failure.
    Abraham AS; Balkin J; Rosenmann D; Brooks BA; Eylath U; Zion MM
    Cardiology; 1988; 75(5):338-43. PubMed ID: 2853002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.